Chapters

Transcript

Video

#TomorrowsDiscoveries: Giving Immune Response a Nano-Boost | Dr. Jonathan Schneck

Name: #TomorrowsDiscoveries: Giving Immune Response a Nano-Boost | Dr. Jonathan Schneck
Uploaded: 2017-01-18T00:00:00+00:00
Description: Can a custom-built white blood cell avoid suppression by cancer and boost our immune system? Dr. Jonathan Schneck has developed “artificial antigen-presenting cells” and is working to put them to use in the clinic.

#TomorrowsDiscoveries: Can a custom-built white blood cell avoid suppression by cancer and boost our immune system? Dr. Jonathan Schneck has developed “artificial antigen-presenting cells” and is working to put them to use in the clinic. Learn more about Dr. Schneck’s work here: http://ow.ly/STwSZ

Created by

Related Presenters

Jonathan Schneck, MD, PhD

Professor of Pathology

Dr. Jonathan Schneck is a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. His research focuses on T cell immunology. His team pioneered ...

View full profile

FOUND IN

Oncology, Research and Innovation

Welcome to
Clinical Connection

The content on this web site is intended for physicians. Patients, please visit hopkinsmedicine.org to learn more about Johns Hopkins patient care and services.

Physicians, discover the latest in biomedical research and clinical innovation from Johns Hopkins experts. Enjoy educational videos and engaging peer-to peer articles, and learn about clinical trials and CME courses available from our world-renowned institution.

For patients-please visit hopkinsmedicine.org to learn more about Johns Hopkins patient care and services.

Refer a Patient

International Patient Services

High-Value Health Care
Learn how we’re improving care and cutting costs for patients

Learn More

Related Videos

Video

Advances in Radiation Oncology: Proton Therapy for Head and Neck Cancer

Dr. Brandi Page presents a head and neck cancer case that demonstrates the benefits of proton therapy and Johns Hopkins' multidisciplinary approach to treatment.

Video

Advances in Medical Oncology for Thoracic Malignancies

Dr. Susan Scott, a fellowship-trained medical oncologist, uses advanced treatments for cancer patients, including early phase clinical trials, targeted therapies and immunomodulation in lung tumors.

Video

Advances in Surgical Approaches for Colorectal Cancers

In this short video, Haniee Chung, fellowship-trained colorectal surgeon, discusses the importance of the tri-modality approach to treating colorectal cancers, total neoadjuvant therapy for rectal cancers and the importance of sphincter-sparing surgery.

Video

5x5 Rectal Cancer Treatment Protocol Q&A

Bashar Safar, chief of colorectal surgery, describes one of the latest approaches against advanced stage rectal cancer: the 5x5 protocol. As an aggressive form of rectal cancer treatment, the 5x5 protocol delivers 5 grays (Gy) of radiation ...

Video

Advances in Lung Sparing Surgery

Dr. Stephen Broderick discusses his use of advanced procedures and the benefits to lung cancer patients, especially those with compromised pulmonary function, the elderly and former smokers.

Video

Advances in Radiation Oncology: Proton Therapy for Breast Cancer

Dr. Jean Wright, fellowship trained radiation oncologist, discusses treatment options for breast cancer, including the use of proton therapy for left breast cancer, and how the multidisciplinary team at Johns Hopkins manages all breast cancer cases.

Video

Advances in Radiation Oncology: Proton Therapy for Lung Cancers

Dr. Curtiland Deville presents a lung tumor case that demonstrates the benefits of organ sparing proton therapy compared to photon therapy.

Video

Combining Chemotherapy and Immunotherapy: The Latest Treatment Options for Head and Neck Cancer

Dr. Karim Boudadi discusses his techniques and use of the most advanced options to treat head and neck cancer.

Video

Cancer Immunotherapy Induced Rheumatic Disease

Laura Cappelli organized an open discussion at #ACR19 among oncologists and rheumatologists to address the rheumatic problems seen in some patients on cancer-fighting checkpoint inhibitors.